M&A, partnerships and new services in pharma outsourcing

New pharma services from M&A and partnerships: round-up

By Natalie Morrison presents the low down on new services forged by partnerships and M&A (mergers and acquisitions), including a molecular biology offering for Quotient, Onyx’s added purification and separation capabilities, and Accenture’s new...

BioFocus: new HTS compound portfolio management system

BioFocus gives itself room to update compound library

By Natalie Morrison

BioFocus has taken on Titian’s sample management software in a bid to pump more resources into “refreshing” its 900,000 strong high-throughput screening (HTS) compound portfolio.

DPT Renaissance acquisition Confab CDMO

No cuts at DPT Labs says new owner Renaissance Pharma

By Gareth Macdonald

No job losses, facility divestitures or strategic changes are planned at DPT Laboratories according to new owner Renaissance Pharma, which bought the CDMO in an out-of-the-blue deal last week. 

Round up of contract manufacturing mergers and acquisitions

Round up of CMO M&A

Outsourcing-Pharma presents a roundup of M&A activity in the CMO space, including Piramal on the hunt for deals and Siegfried buying AMP.

Private equity to buy SeraCare

Private equity to buy SeraCare

By Nick Taylor

SeraCare Life Sciences has accepted an $82m offer from a US private equity firm six months after it began searching for a buyer.

Follow us


View more